Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy
For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus o...
Saved in:
Published in | Current urology reports Vol. 16; no. 11; p. 75 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.11.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 1527-2737 1534-6285 1534-6285 |
DOI | 10.1007/s11934-015-0547-1 |
Cover
Abstract | For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus on patients eligible for radical cystectomy, for whom a comparison of patient-reported outcomes is most relevant. Peer-reviewed, English-language manuscripts in MEDLINE and PubMed databases were examined from 1996 through 2014. Subject headings included quality of life, bladder cancer, bladder sparing, bladder preservation, radiation, and radiotherapy. Prospective and retrospective studies of patient-reported outcomes in patients undergoing bladder preservation with radiotherapy for muscle-invasive bladder cancer were included. Two prospective studies and four retrospective studies were identified. Several weaknesses from these studies were identified including small sample sizes, variable time points of assessment, variation in treatment regimens, and failure to use validated or condition-specific questionnaires. From the available data, bladder preservation appears to result to similar or better general quality of life compared to radical cystectomy with satisfactory urinary and sexual function reported in most series. In general, bladder preservation resulted in more gastrointestinal symptoms than radical cystectomy. This is one of the first reviews on the subject of patient-reported outcomes for bladder preservation in muscle-invasive bladder cancer. Although the data are limited, this review may provide a framework for developing well-designed, prospective comparisons of treatment for this patient cohort. |
---|---|
AbstractList | For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus on patients eligible for radical cystectomy, for whom a comparison of patient-reported outcomes is most relevant. Peer-reviewed, English-language manuscripts in MEDLINE and PubMed databases were examined from 1996 through 2014. Subject headings included quality of life, bladder cancer, bladder sparing, bladder preservation, radiation, and radiotherapy. Prospective and retrospective studies of patient-reported outcomes in patients undergoing bladder preservation with radiotherapy for muscle-invasive bladder cancer were included. Two prospective studies and four retrospective studies were identified. Several weaknesses from these studies were identified including small sample sizes, variable time points of assessment, variation in treatment regimens, and failure to use validated or condition-specific questionnaires. From the available data, bladder preservation appears to result to similar or better general quality of life compared to radical cystectomy with satisfactory urinary and sexual function reported in most series. In general, bladder preservation resulted in more gastrointestinal symptoms than radical cystectomy. This is one of the first reviews on the subject of patient-reported outcomes for bladder preservation in muscle-invasive bladder cancer. Although the data are limited, this review may provide a framework for developing well-designed, prospective comparisons of treatment for this patient cohort. For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus on patients eligible for radical cystectomy, for whom a comparison of patient-reported outcomes is most relevant. Peer-reviewed, English-language manuscripts in MEDLINE and PubMed databases were examined from 1996 through 2014. Subject headings included quality of life, bladder cancer, bladder sparing, bladder preservation, radiation, and radiotherapy. Prospective and retrospective studies of patient-reported outcomes in patients undergoing bladder preservation with radiotherapy for muscle-invasive bladder cancer were included. Two prospective studies and four retrospective studies were identified. Several weaknesses from these studies were identified including small sample sizes, variable time points of assessment, variation in treatment regimens, and failure to use validated or condition-specific questionnaires. From the available data, bladder preservation appears to result to similar or better general quality of life compared to radical cystectomy with satisfactory urinary and sexual function reported in most series. In general, bladder preservation resulted in more gastrointestinal symptoms than radical cystectomy. This is one of the first reviews on the subject of patient-reported outcomes for bladder preservation in muscle-invasive bladder cancer. Although the data are limited, this review may provide a framework for developing well-designed, prospective comparisons of treatment for this patient cohort.For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival differences, toxicity, and quality of life. Our objective was to review patient-reported outcomes for bladder preservation treatment with a focus on patients eligible for radical cystectomy, for whom a comparison of patient-reported outcomes is most relevant. Peer-reviewed, English-language manuscripts in MEDLINE and PubMed databases were examined from 1996 through 2014. Subject headings included quality of life, bladder cancer, bladder sparing, bladder preservation, radiation, and radiotherapy. Prospective and retrospective studies of patient-reported outcomes in patients undergoing bladder preservation with radiotherapy for muscle-invasive bladder cancer were included. Two prospective studies and four retrospective studies were identified. Several weaknesses from these studies were identified including small sample sizes, variable time points of assessment, variation in treatment regimens, and failure to use validated or condition-specific questionnaires. From the available data, bladder preservation appears to result to similar or better general quality of life compared to radical cystectomy with satisfactory urinary and sexual function reported in most series. In general, bladder preservation resulted in more gastrointestinal symptoms than radical cystectomy. This is one of the first reviews on the subject of patient-reported outcomes for bladder preservation in muscle-invasive bladder cancer. Although the data are limited, this review may provide a framework for developing well-designed, prospective comparisons of treatment for this patient cohort. |
ArticleNumber | 75 |
Author | Goenka, Anuj Feuerstein, Michael A. |
Author_xml | – sequence: 1 givenname: Michael A. surname: Feuerstein fullname: Feuerstein, Michael A. email: Mfeuerste1@nshs.edu organization: Department of Urology, Lenox Hill Hospital, Hofstra-North Shore LIJ School of Medicine – sequence: 2 givenname: Anuj surname: Goenka fullname: Goenka, Anuj organization: Department of Radiation Medicine, Lenox Hill Hospital, Hofstra-North Shore LIJ School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26343030$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU1v2zAMhoWhxfr5A3opdNzFm2jZknPcgq0bEKAfaM6CJNOpCkfKJLlD_v2UJt1hh55IEM9DgHzPyJEPHgm5AvYZGJNfEsCMNxWDtmJtIyv4QE6hLRNRd-3Rrq9lVUsuT8hZSs-M1Yx1zUdyUgvecMbZKRnuJz26vKVhoAs3IL2dsg1rTHQIkX4bdd9jpHPtbSl3Ojv0OdGlL9NVcH71D7mLmDC-FCJ4-sflJ_qgexfyE0a92V6Q40GPCS8P9Zwsf3x_nP-sFrc3v-ZfF5XlTZOrrudc9oZZZmzHcNZ0IICDldL2wuhW8g5aI9pyGEeOiKYfjBFCgzDYGMHPyaf93k0MvydMWa1dsjiO2mOYkgIJrG5BzuqCXh_QyayxV5vo1jpu1dtvCiD3gI0hpYiDsi6_3pejdqMCpnYpqH0KqqSgdikoKCb8Z74tf8-p904qrF9hVM9hir486x3pLz7HmZ0 |
CitedBy_id | crossref_primary_10_1111_iju_13495 crossref_primary_10_1371_journal_pone_0161886 crossref_primary_10_1007_s11136_016_1493_1 crossref_primary_10_1007_s11136_020_02544_z crossref_primary_10_1111_bju_15864 crossref_primary_10_3233_BLC_210011 crossref_primary_10_3390_molecules21101406 crossref_primary_10_3390_radiation2040025 crossref_primary_10_1155_2016_9174903 crossref_primary_10_15407_exp_oncology_2024_04_351 crossref_primary_10_1016_j_clgc_2018_09_023 crossref_primary_10_1016_j_canrad_2020_04_014 crossref_primary_10_1186_s13014_023_02338_w crossref_primary_10_1016_j_bbrc_2017_04_009 crossref_primary_10_1136_flgastro_2020_101430 crossref_primary_10_1016_j_ijrobp_2016_08_023 crossref_primary_10_3389_fphar_2021_684915 crossref_primary_10_1177_11772719241297168 crossref_primary_10_1007_s00345_018_2606_y crossref_primary_10_1038_nrclinonc_2016_79 crossref_primary_10_1016_j_urolonc_2023_07_005 crossref_primary_10_1016_j_clon_2017_01_040 crossref_primary_10_3233_BLC_190233 crossref_primary_10_3892_ijo_2016_3606 |
Cites_doi | 10.1001/jama.2013.879 10.1016/j.urology.2004.02.024 10.1016/j.radonc.2003.05.001 10.1002/(SICI)1097-0142(19960901)78:5<1089::AID-CNCR20>3.0.CO;2-Y 10.1023/A:1025144617752 10.1377/hlthaff.2014.0225 10.1016/S0360-3016(00)00653-2 10.1016/S0167-8140(01)00455-8 10.1200/JCO.2008.19.5776 10.1097/01.ju.0000149080.82697.65 10.1016/j.eururo.2008.07.031 10.1080/02841860802251575 10.1016/S0167-8140(98)00109-1 10.1097/01.ju.0000093721.23249.c3 10.1200/JCO.2012.42.5967 10.1016/j.ijrobp.2009.10.038 10.1200/JCO.2014.58.5521 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media New York 2015 |
Copyright_xml | – notice: Springer Science+Business Media New York 2015 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1007/s11934-015-0547-1 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1534-6285 |
ExternalDocumentID | 26343030 10_1007_s11934_015_0547_1 |
Genre | Journal Article Review |
GroupedDBID | --- -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 203 29F 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 4.4 406 408 40D 40E 53G 5GY 5VS 6NX 875 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACREN ACSNA ACZOJ ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGAL AEGNC AEGXH AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ AXYYD B-. BA0 BDATZ BGNMA C1A CAG COF CS3 CSCUP CUW DDRTE DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 H13 HF~ HG6 HMJXF HRMNR HZ~ IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE I~Z J-C JBSCW JZLTJ KOV LLZTM M4Y MA- N9A NPVJJ NQJWS NU0 O9- O9J P9S PF0 PT4 QOR QOS R89 R9I ROL RPX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z7U Z82 Z87 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION ABRTQ CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c344t-8d337db0c0bc80e94816131c77cd6ba573815b651523e3eeebdfbb66a16be4b63 |
IEDL.DBID | U2A |
ISSN | 1527-2737 1534-6285 |
IngestDate | Sun Aug 24 04:05:57 EDT 2025 Mon Jul 21 05:41:35 EDT 2025 Thu Apr 24 22:54:56 EDT 2025 Tue Jul 01 02:08:52 EDT 2025 Fri Feb 21 02:36:38 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Patient-reported outcomes Radiotherapy Bladder cancer Quality of life |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c344t-8d337db0c0bc80e94816131c77cd6ba573815b651523e3eeebdfbb66a16be4b63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
PMID | 26343030 |
PQID | 1710251792 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_1710251792 pubmed_primary_26343030 crossref_citationtrail_10_1007_s11934_015_0547_1 crossref_primary_10_1007_s11934_015_0547_1 springer_journals_10_1007_s11934_015_0547_1 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-11-01 |
PublicationDateYYYYMMDD | 2015-11-01 |
PublicationDate_xml | – month: 11 year: 2015 text: 2015-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States |
PublicationTitle | Current urology reports |
PublicationTitleAbbrev | Curr Urol Rep |
PublicationTitleAlternate | Curr Urol Rep |
PublicationYear | 2015 |
Publisher | Springer US |
Publisher_xml | – name: Springer US |
References | Shabsigh, Korets, Vora (CR3) 2009; 55 CR4 Howie, Hirsch, Locklear (CR6) 2014; 33 Caffo, Fellin, Graffer (CR11) 1996; 78 CR5 Calvert, Blazeby, Altman (CR18) 2013; 309 CR9 Porter, Penson (CR2) 2005; 173 Botteman, Pashos, Hauser (CR1) 2003; 12 CR13 Henningsohn, Wijkstrom, Dickman (CR7) 2002; 62 Zietman, Sacco, Skowronski (CR10) 2003; 170 Roeske, Bonta, Mell (CR16) 2003; 69 Herman, Smith, Montie (CR8) 2004; 64 Efstathiou, Bae, Shipley (CR14) 2009; 27 Sondergaard, Hoyer, Petersen (CR17) 2009; 48 Nutting, Convery, Cosgrove (CR15) 2000; 48 Little, Howard (CR12) 1998; 49 J Sondergaard (547_CR17) 2009; 48 JM Herman (547_CR8) 2004; 64 547_CR5 547_CR4 O Caffo (547_CR11) 1996; 78 A Shabsigh (547_CR3) 2009; 55 L Howie (547_CR6) 2014; 33 547_CR13 MF Botteman (547_CR1) 2003; 12 JC Roeske (547_CR16) 2003; 69 M Calvert (547_CR18) 2013; 309 FA Little (547_CR12) 1998; 49 JA Efstathiou (547_CR14) 2009; 27 547_CR9 AL Zietman (547_CR10) 2003; 170 CM Nutting (547_CR15) 2000; 48 L Henningsohn (547_CR7) 2002; 62 MP Porter (547_CR2) 2005; 173 23071244 - J Clin Oncol. 2012 Dec 1;30(34):4249-55 14532773 - J Urol. 2003 Nov;170(5):1772-6 11937249 - Radiother Oncol. 2002 Feb;62(2):215-25 18675501 - Eur Urol. 2009 Jan;55(1):164-74 25366679 - J Clin Oncol. 2014 Dec 1;32(34):3787-8 8780548 - Cancer. 1996 Sep 1;78(5):1089-97 14643959 - Radiother Oncol. 2003 Nov;69(2):201-7 10052881 - Radiother Oncol. 1998 Nov;49(2):157-61 25006149 - Health Aff (Millwood). 2014 Jul;33(7):1220-8 23443445 - JAMA. 2013 Feb 27;309(8):814-22 14516177 - Qual Life Res. 2003 Sep;12(6):675-88 11020560 - Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):649-56 18759144 - Acta Oncol. 2009;48(2):238-44 19636019 - J Clin Oncol. 2009 Sep 1;27(25):4055-61 15245938 - Urology. 2004 Jul;64(1):69-73 15758789 - J Urol. 2005 Apr;173(4):1318-22 |
References_xml | – volume: 309 start-page: 814 year: 2013 ident: CR18 article-title: Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension publication-title: JAMA doi: 10.1001/jama.2013.879 – volume: 64 start-page: 69 year: 2004 ident: CR8 article-title: Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy publication-title: Urology doi: 10.1016/j.urology.2004.02.024 – volume: 69 start-page: 201 year: 2003 ident: CR16 article-title: A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy publication-title: Radiother Oncol doi: 10.1016/j.radonc.2003.05.001 – volume: 78 start-page: 1089 year: 1996 ident: CR11 article-title: Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. a survey by a self-administered questionnaire publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19960901)78:5<1089::AID-CNCR20>3.0.CO;2-Y – volume: 12 start-page: 675 year: 2003 ident: CR1 article-title: Quality of life aspects of bladder cancer: a review of the literature publication-title: Qual Life Res doi: 10.1023/A:1025144617752 – ident: CR4 – volume: 33 start-page: 1220 year: 2014 ident: CR6 article-title: Assessing the value of patient-generated data to comparative effectiveness research publication-title: Health Aff (Millwood) doi: 10.1377/hlthaff.2014.0225 – volume: 48 start-page: 649 year: 2000 ident: CR15 article-title: Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(00)00653-2 – volume: 62 start-page: 215 year: 2002 ident: CR7 article-title: Distressful symptoms after radical radiotherapy for urinary bladder cancer publication-title: Radiother Oncol doi: 10.1016/S0167-8140(01)00455-8 – volume: 27 start-page: 4055 year: 2009 ident: CR14 article-title: Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89–03, 95–06, 97–06, 99–06 publication-title: J Clin Oncol doi: 10.1200/JCO.2008.19.5776 – ident: CR13 – volume: 173 start-page: 1318 year: 2005 ident: CR2 article-title: Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature publication-title: J Urol doi: 10.1097/01.ju.0000149080.82697.65 – volume: 55 start-page: 164 year: 2009 ident: CR3 article-title: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology publication-title: Eur Urol doi: 10.1016/j.eururo.2008.07.031 – ident: CR9 – volume: 48 start-page: 238 year: 2009 ident: CR17 article-title: The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy publication-title: Acta Oncol doi: 10.1080/02841860802251575 – volume: 49 start-page: 157 year: 1998 ident: CR12 article-title: Sexual function following radical radiotherapy for bladder cancer publication-title: Radiother Oncol doi: 10.1016/S0167-8140(98)00109-1 – ident: CR5 – volume: 170 start-page: 1772 year: 2003 ident: CR10 article-title: Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors publication-title: J Urol doi: 10.1097/01.ju.0000093721.23249.c3 – volume: 48 start-page: 649 year: 2000 ident: 547_CR15 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/S0360-3016(00)00653-2 – volume: 309 start-page: 814 year: 2013 ident: 547_CR18 publication-title: JAMA doi: 10.1001/jama.2013.879 – volume: 173 start-page: 1318 year: 2005 ident: 547_CR2 publication-title: J Urol doi: 10.1097/01.ju.0000149080.82697.65 – volume: 48 start-page: 238 year: 2009 ident: 547_CR17 publication-title: Acta Oncol doi: 10.1080/02841860802251575 – volume: 33 start-page: 1220 year: 2014 ident: 547_CR6 publication-title: Health Aff (Millwood) doi: 10.1377/hlthaff.2014.0225 – volume: 49 start-page: 157 year: 1998 ident: 547_CR12 publication-title: Radiother Oncol doi: 10.1016/S0167-8140(98)00109-1 – volume: 55 start-page: 164 year: 2009 ident: 547_CR3 publication-title: Eur Urol doi: 10.1016/j.eururo.2008.07.031 – volume: 62 start-page: 215 year: 2002 ident: 547_CR7 publication-title: Radiother Oncol doi: 10.1016/S0167-8140(01)00455-8 – ident: 547_CR5 doi: 10.1200/JCO.2012.42.5967 – volume: 27 start-page: 4055 year: 2009 ident: 547_CR14 publication-title: J Clin Oncol doi: 10.1200/JCO.2008.19.5776 – volume: 64 start-page: 69 year: 2004 ident: 547_CR8 publication-title: Urology doi: 10.1016/j.urology.2004.02.024 – volume: 12 start-page: 675 year: 2003 ident: 547_CR1 publication-title: Qual Life Res doi: 10.1023/A:1025144617752 – ident: 547_CR4 – ident: 547_CR9 doi: 10.1016/j.ijrobp.2009.10.038 – ident: 547_CR13 doi: 10.1200/JCO.2014.58.5521 – volume: 170 start-page: 1772 year: 2003 ident: 547_CR10 publication-title: J Urol doi: 10.1097/01.ju.0000093721.23249.c3 – volume: 69 start-page: 201 year: 2003 ident: 547_CR16 publication-title: Radiother Oncol doi: 10.1016/j.radonc.2003.05.001 – volume: 78 start-page: 1089 year: 1996 ident: 547_CR11 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19960901)78:5<1089::AID-CNCR20>3.0.CO;2-Y – reference: 15245938 - Urology. 2004 Jul;64(1):69-73 – reference: 23071244 - J Clin Oncol. 2012 Dec 1;30(34):4249-55 – reference: 25006149 - Health Aff (Millwood). 2014 Jul;33(7):1220-8 – reference: 8780548 - Cancer. 1996 Sep 1;78(5):1089-97 – reference: 11020560 - Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):649-56 – reference: 10052881 - Radiother Oncol. 1998 Nov;49(2):157-61 – reference: 14643959 - Radiother Oncol. 2003 Nov;69(2):201-7 – reference: 18759144 - Acta Oncol. 2009;48(2):238-44 – reference: 11937249 - Radiother Oncol. 2002 Feb;62(2):215-25 – reference: 14516177 - Qual Life Res. 2003 Sep;12(6):675-88 – reference: 18675501 - Eur Urol. 2009 Jan;55(1):164-74 – reference: 19636019 - J Clin Oncol. 2009 Sep 1;27(25):4055-61 – reference: 23443445 - JAMA. 2013 Feb 27;309(8):814-22 – reference: 15758789 - J Urol. 2005 Apr;173(4):1318-22 – reference: 14532773 - J Urol. 2003 Nov;170(5):1772-6 – reference: 25366679 - J Clin Oncol. 2014 Dec 1;32(34):3787-8 |
SSID | ssj0020084 |
Score | 2.1748078 |
SecondaryResourceType | review_article |
Snippet | For patients with muscle-invasive bladder cancer, the decision to undergo radical cystectomy or bladder preservation treatment must incorporate survival... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 75 |
SubjectTerms | Combined Modality Therapy Cystectomy - methods Humans Medicine Medicine & Public Health Neoplasm Invasiveness Nephrology Quality of Life Section Editor Topical Collection on Urothelial Cancer Treatment Outcome Urinary Bladder Neoplasms - radiotherapy Urinary Bladder Neoplasms - therapy Urology Urothelial Cancer (A Sagalowsky |
Title | Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy |
URI | https://link.springer.com/article/10.1007/s11934-015-0547-1 https://www.ncbi.nlm.nih.gov/pubmed/26343030 https://www.proquest.com/docview/1710251792 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS8MwEA_iQHwRv60fI4JPSqFt2qR7nGNzqFMRB_OpNF8yGK2s3cP-e3P9GjIVfE8TenfJ_ZK7-x1CV0woSmjcsTWDMGMncGyunNCWMtRE-Vq7EgqcR090OPbvJ8GkquPO6mz3OiRZnNSrYjeDNSBjIrANzGC2ufK0AqCTMkY89rrNLQsY4guSVI9B3QmrQ5k_TfHdGa0hzLXoaOF0Brtop0KLuFuqdw9tqGQfbY2qePgB0iUFxhKnGj9OtcLPi9z8jcqwwaL4dgbHyhz3QLNz_FJSqGa46HX0kZoVmyGQiVE_z2J4m8WvsZxW1VnLQzQe9N96Q7vqnGAL4vu5HUpCmOSOcLgIHQWMLMZtu4IxISmPA2b8dMChC7pHFFFKcak5pzR2KVc-p-QIbSZpok4Q5tqPVWiOATOJcWSko4XHqBMTKiRsfws5tQgjUdGKQ3eLWbQiRAapR0bqEUg9ci103XzyWXJq_DX4stZLZCwfwhlxotJFFrkAjoBhzLPQcamwZjqPEt84Z8dCN7UGo2pzZr-vdfqv0Wdo2wNTKgoTz9FmPl-oC4NQct5Gre7d-0O_XVjmFw3d3Rs |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS8MwFA4yQX0R79ZrBJ-UQtu0Sfc4h2PqNkU22FtobjIYnazbw_69Ob1syFTwPU3oOUnOl3w530HolklNCU3qrmFAM9YjzxXai12lYkN0aIyvIMG526PtQfg8jIZlHndWvXavKMl8p14lu1msAS8mItfCDObaI88msIxw4hoEjeUpCxTic5HUgEHeCauozJ-6-B6M1hDmGjuaB53WHtot0SJuFO7dRxs6PUBb3ZIPP0SmkMBY4InBnZHR-HU-s3-jM2yxKH4Yw7YyxU3w7BS_FRKqGc5rHX1M7IjLJvASo7qexXA3i98TNSqzsxZHaNB67Dfbblk5wZUkDGdurAhhSnjSEzL2NCiy2LDtS8akoiKJmI3TkYAq6AHRRGstlBGC0sSnQoeCkmNUSyepPkVYmDDRsd0GbCc2kJG6kQGjXkKoVLD8HeRVJuSylBWH6hZjvhJEBqtza3UOVue-g-6Wn3wWmhp_Nb6p_MLtzAc6I0n1ZJ5xH8ARKIwFDjopHLbsLqAktMHZc9B95UFeLs7s97HO_tX6Gm23-90O7zz1Xs7RTgDTKk9SvEC12XSuLy1amYmrfHZ-AYQL3mo |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED9NRap4YWN8rLAxI_EECiRxYqePXaHjq4AQSPBk4q8JDaWoSR-6v36-JilihUmId8d2fOfzz7673wFscWUYZWnbsxzdjO3Y96TxE0_rxFITWRtoTHDun7HD6-j4Jr6p6pzmdbR77ZIscxqQpSkr9h613XtKfHO4A6MnYs9BDu65689chCUkGjDX-Xl7cjC9cyFf_IQyNeSYhcJrx-ZLnTw_mmbw5oyvdHIE9T7CXT35MvLk9-6okLvqzz-8ju_4u0-wUMFT0in1aRE-mOwzNPuVA34JbMm5MSYDS07vrSHno8INYHLiwC_58YB2bEi6qEpDclFytuZkUlzp18DNZ9oEQz_q92CCj8HkMtX3VTrYeBmuewdX3UOvKtXgKRpFhZdoSrmWvvKlSnyDFDAOJwSKc6WZTGPugEEssex6SA01xkhtpWQsDZg0kWR0BRrZIDNfgEgbpSZxdsd14k5O2rYq5MxPKVMa7U0L_FpKQlU85lhO40E8MTDj-gm3fgLXTwQt2J5-8liSePyv8WYteuG2GvpP0swMRrkIEI0hpVnYgtVSJ6bdhYxGDg34Ldip5Ssqa5C_Ptbam1p_h-bFfk-cHp2drMN8iPoxSYr8Co1iODLfHDoq5Ea1A_4ChQcEHQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quality+of+Life+Outcomes+for+Bladder+Cancer+Patients+Undergoing+Bladder+Preservation+with+Radiotherapy&rft.jtitle=Current+urology+reports&rft.au=Feuerstein%2C+Michael+A&rft.au=Goenka%2C+Anuj&rft.date=2015-11-01&rft.issn=1534-6285&rft.eissn=1534-6285&rft.volume=16&rft.issue=11&rft.spage=75&rft_id=info:doi/10.1007%2Fs11934-015-0547-1&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-2737&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-2737&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-2737&client=summon |